BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 33980944)

  • 1. Predictive role of circulatory HMGB1 in postoperative acute exacerbation of interstitial lung disease in lung cancer patients.
    Yamaguchi K; Nakao S; Iwamoto H; Kagimoto A; Handa Y; Sakamoto S; Horimasu Y; Masuda T; Mimae T; Miyamoto S; Nakashima T; Tsutani Y; Fujitaka K; Miyata Y; Hamada H; Okada M; Hattori N
    Sci Rep; 2021 May; 11(1):10105. PubMed ID: 33980944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum high-mobility group box 1 as a predictive marker for cytotoxic chemotherapy-induced lung injury in patients with lung cancer and interstitial lung disease.
    Nakao S; Yamaguchi K; Iwamoto H; Sakamoto S; Horimasu Y; Masuda T; Miyamoto S; Nakashima T; Ohshimo S; Fujitaka K; Hamada H; Hattori N
    Respir Med; 2020 Oct; 172():106131. PubMed ID: 32911136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surgical outcomes and perioperative risk factors of patients with interstitial lung disease after pulmonary resection.
    Huang C; Sun YG; Ma C; Jiao P; Wu QJ; Tian WX; Yu HB; Tong HF
    J Cardiothorac Surg; 2024 Feb; 19(1):72. PubMed ID: 38331909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Associations between Comorbidities and Acute Exacerbation of Interstitial Lung Disease after Primary Lung Cancer Surgery.
    Kato T; Miyoshi S; Hamada C; Sano Y; Nogami N; Yamaguchi O; Hamaguchi N
    Acta Med Okayama; 2023 Jun; 77(3):301-309. PubMed ID: 37357631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HMGB1 May Be a Biomarker for Predicting the Outcome in Patients with Polymyositis /Dermatomyositis with Interstitial Lung Disease.
    Shu X; Peng Q; Lu X; Wang G
    PLoS One; 2016; 11(8):e0161436. PubMed ID: 27537498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum S100 calcium-binding protein A4 as a novel predictive marker of acute exacerbation of interstitial pneumonia after surgery for lung cancer.
    Kagimoto A; Tsutani Y; Kushitani K; Kambara T; Mimae T; Miyata Y; Takeshima Y; Okada M
    BMC Pulm Med; 2021 Jun; 21(1):186. PubMed ID: 34078355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of serum oncomarkers for patients hospitalized with acute exacerbation of interstitial lung disease.
    Ba C; Jiang C; Wang H; Shi X; Jin J; Fang Q
    Ther Adv Respir Dis; 2024; 18():17534666241250332. PubMed ID: 38757948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High preoperative C-reactive protein level is a risk factor for acute exacerbation of interstitial lung disease after non-pulmonary surgery.
    Takao S; Masuda T; Yamaguchi K; Sakamoto S; Horimasu Y; Nakashima T; Miyamoto S; Iwamoto H; Fujitaka K; Hamada H; Hattori N
    Medicine (Baltimore); 2019 Feb; 98(5):e14296. PubMed ID: 30702600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chest-tube drainage is a sign of acute exacerbation of interstitial lung disease associated with lung cancer.
    Maniwa T; Isaka M; Nakagawa K; Ohde Y; Okumura T; Endo M; Kondo H
    Surg Today; 2013 Apr; 43(4):408-11. PubMed ID: 23180119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum high-mobility group box 1 is associated with the onset and severity of acute exacerbation of idiopathic pulmonary fibrosis.
    Yamaguchi K; Iwamoto H; Sakamoto S; Horimasu Y; Masuda T; Miyamoto S; Nakashima T; Ohshimo S; Fujitaka K; Hamada H; Hattori N
    Respirology; 2020 Mar; 25(3):275-280. PubMed ID: 31270920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The extent of ground-glass attenuation is a risk factor of chemotherapy-related exacerbation of interstitial lung disease in patients with non-small cell lung cancer.
    Masuda T; Hirano C; Horimasu Y; Nakashima T; Miyamoto S; Iwamoto H; Ohshimo S; Fujitaka K; Hamada H; Hattori N
    Cancer Chemother Pharmacol; 2018 Jan; 81(1):131-139. PubMed ID: 29143072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of Soluble Receptor for Advanced Glycation End Products in Postoperative Fibrotic Lung Injury.
    Nakao S; Yamaguchi K; Iwamoto H; Kagimoto A; Mimae T; Tsutani Y; Miyata Y; Hamada H; Okada M; Hattori N
    Ann Thorac Surg; 2022 May; 113(5):1617-1623. PubMed ID: 34139190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Surgical Treatment of Lung Cancer Combined with Interstitial Lung Disease].
    Huang C; Ma C; Wu Q; Jiao P; Sun Y; Tian W; Yu H; Huang W; Wang Y; Tong H
    Zhongguo Fei Ai Za Zhi; 2020 May; 23(5):343-350. PubMed ID: 32429636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive value of
    Akaike K; Saruwatari K; Oda S; Shiraishi S; Takahashi H; Hamada S; Iyama S; Horio Y; Tomita Y; Saeki S; Okamoto S; Ichiyasu H; Fujii K; Sakagami T
    Int J Clin Oncol; 2020 Apr; 25(4):681-690. PubMed ID: 31781994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low forced vital capacity predicts cytotoxic chemotherapy-associated acute exacerbation of interstitial lung disease in patients with lung cancer.
    Enomoto Y; Inui N; Kato T; Baba T; Karayama M; Nakamura Y; Ogura T; Suda T
    Lung Cancer; 2016 Jun; 96():63-7. PubMed ID: 27133752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Interstitial Lung Disease-Gender-Age-Physiology Index Can Predict the Prognosis in Surgically Resected Patients with Interstitial Lung Disease and Concomitant Lung Cancer.
    Ueno F; Kitaguchi Y; Shiina T; Asaka S; Yasuo M; Wada Y; Kinjo T; Yoshizawa A; Hanaoka M
    Respiration; 2020; 99(1):9-18. PubMed ID: 31554007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is operation safe for lung cancer patients with interstitial lung disease on computed tomography?
    Tang H; Ren Y; She Y; Dai C; Wang T; Su H; Sun W; Jiang G; Chen C
    Ther Adv Respir Dis; 2020; 14():1753466620971137. PubMed ID: 33167797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glasgow prognostic score for prediction of chemotherapy-triggered acute exacerbation interstitial lung disease in patients with small cell lung cancer.
    Kikuchi R; Takoi H; Tsuji T; Nagatomo Y; Tanaka A; Kinoshita H; Ono M; Ishiwari M; Toriyama K; Kono Y; Togashi Y; Yamaguchi K; Yoshimura A; Abe S
    Thorac Cancer; 2021 Jun; 12(11):1681-1689. PubMed ID: 33939332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of serum high-mobility group box protein 1 level with outcomes of acute exacerbation of idiopathic pulmonary fibrosis and fibrosing nonspecific interstitial pneumonia.
    Shimizu H; Sakamoto S; Isshiki T; Furuya K; Kurosaki A; Homma S
    PLoS One; 2018; 13(5):e0196558. PubMed ID: 29795561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute exacerbation of interstitial lung disease with lung cancer after surgery: evaluation with 2-[18]-fluoro-2-deoxy-D-glucose positron emission tomography.
    Maniwa T; Endo M; Isaka M; Nakagawa K; Ohde Y; Okumura T; Kondo H
    Surg Today; 2014 Mar; 44(3):494-8. PubMed ID: 24006127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.